Multilayered Chitosan-DNA Nanoparticles for Podocyte Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering nucleic acids into cells, particularly podocytes, face challenges such as unsatisfactory targeting and transfection properties of polycations, uncontrollable nanoparticle sizes, and inefficient gene therapy due to low expression rates and immune reactions.
Innovation Solution
Nanoparticles with a multilayered shell composed of alternate bilayers of chitosan derivatives and non-viral expression DNA vectors are fabricated using layer-by-layer deposition, allowing for controlled and targeted delivery of therapeutic genes, specifically silencing CMIP in podocytes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If polycations are used for nucleic acid delivery, then transfection efficiency is improved, but targeting properties and transfection properties remain unsatisfactory
Solution Approach 1:
The patent applies local quality by creating multilayered assemblies with distinct functional zones: inner layers provide transfection efficiency through polycation-nucleic acid complexation, while outer layers provide targeting specificity through engineered ligands or surface modifications. This spatial differentiation of properties resolves the contradiction between transfection efficiency and targeting reliability.
Solution Approach 2:
The invention uses composite materials by combining polycations with nucleic acids to form multilayered assemblies that integrate multiple functions within a single delivery system. The composite structure allows simultaneous achievement of transfection efficiency (from polycation properties) and targeting reliability (from integrated targeting moieties).
2Productivity
If viral vectors are used for gene delivery, then transfection efficiency is improved, but immune reactions and low expression rates occur
Solution Approach 1:
The patent employs disposable, biodegradable polycation-based multilayered assemblies that perform their delivery function and then degrade harmlessly, replacing persistent viral vectors. These temporary delivery vehicles provide transfection efficiency without the long-term immune reactions associated with viral vectors, as they are designed to be metabolized after delivering their payload.
Solution Approach 2:
The invention extracts the harmful immune-reactive components from the delivery system by removing viral elements entirely, retaining only the essential transfection function through polycation-nucleic acid complexes. This extraction eliminates immune reactions while preserving transfection efficiency through carefully engineered multilayered structures.
3Stability of the object's composition
If nanoparticles are used for RNA delivery, then stabilization is improved, but size control and RNA quantity tuning become difficult
Solution Approach 1:
The patent applies dynamics by creating tunable multilayered assemblies where the number of bilayers, thickness of each layer, and composition ratios can be dynamically adjusted during fabrication. This dynamic control enables precise tuning of nanoparticle size and RNA loading capacity while maintaining RNA stabilization through the protective multilayered structure.
Solution Approach 2:
The invention uses parameter changes by systematically varying fabrication conditions such as deposition time, polymer concentration, ionic strength, and pH to control nanoparticle size and RNA content. These parameter adjustments allow precise control over particle characteristics while maintaining RNA stabilization through the protective multilayered architecture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles enable efficient and controlled delivery of therapeutic genes into podocytes, effectively silencing CMIP and preventing proteinuria, demonstrating potential for treating podocyte diseases like idiopathic nephrotic syndrome.
Implementation Method 1
a multilayered shell composed of alternate bilayers of one positively charged layer comprising at least one chitosan derivative and of one negatively charged layer comprising or consisting of at least one non-viral expression DNA vector
Data Source
AI summary
The present invention relates to the localized delivery of nucleic acids to cells using polyelectrolyte assemblies in the form of particles that are prepared by layer-by-layer deposition of nucleic acid and specific polycation. It also relates to compositions comprising said particles and methods for the treatment of disorders or diseases by administration of such particles.